I agree.
And why would someone with these credential just recently sign on with this company if it were about to go down the tubes? Certainly she asked a few pertinent questions and would possess the experience, education and knowledge to know a loser when she sees it. And why would Peregrine hire someone for worldwide business development if they thought they were close to closing the doors? Doesn't make sense...
Dr. Boyd was previously director, Asia, worldwide business development, R&D for GlaxoSmithKline; head of business development and licensing for Japan for Novartis; and head, licensing and patent group for Roche in Japan. In these positions, she identified new opportunities, negotiated global agreements and maintained productive relationships with other companies. Dr. Boyd holds a Ph.D. in Developmental Genetics from the University of Cambridge, UK and a B.Sc in Biochemistry from the University of Sussex, UK.
News 
Market Data 
Discover 
